METUCHEN, N.J.–(BUSINESS WIRE)–MouthWatch, LLC, an industry leader in teledentistry solutions and dental intraoral cameras, is marking 2023 as a year defined by its commitment...
Femtech, or female technology, is a rapidly growing industry that focuses on developing innovative solutions to address women's health issues. From menstrual tracking apps...
Health Innovation Hub & Holding GmbH (Innovation in Health) has just launched 8 open innovation challenges, with the aim of fostering collaboration between the...
Building on the success of the Women’s Health Innovation Summit Europe 2022, the WHIS team is returning to Switzerland (27-28 April). The impact-driven Summit...
By Robert Krayn
COVID proved how indispensable telehealth is to mental health care. Nearly 40% of American adults reported anxiety or depression symptoms...
BASINGSTOKE, England–(BUSINESS WIRE)–#awards—Juniper Research is pleased to announce the opening of the Future Digital Awards for Digital Health Innovation 2022! Since 2008, the Future Digital Awards have been awarded to tech companies at the forefront of their respective fields: companies that deliver imaginative and innovative products or services that have the potential to disrupt their […]
On December 13, Baxter International Inc. (“Baxter”) announced the completion of one of the biggest medtech acquisitions of 2021, acquiring Hillrom (a global medical equipment maker headquartered in Chicago) for a purchase price of ~$10.5 billion. The deal had originally been announced by Baxter in September 2021.
According to a statement on Baxter’s website, “Baxter’s acquisition of Hillrom has formed one of the world’s leading medical technology companies, centered around a shared vision to transform healthcare.”
Baxter’s product portfolio includes diagnostic, critical care, kidney care, nutrition, and surgical products used in hospitals, physician offices, and patient homes. According to Baxter, the addition of Hillrom’s product lines, including legacy Welch Allyn products that were acquired by Hillrom in 2015, will help Baxter improve care outcomes and broaden access to care. Hillrom’s products include the MacroView® Plus Otoscope, the Volara™ Oscillation & Lung Expansion Therapy System, the PST 500 Precision Surgical Table, and the Centrella® Smart+ Bed.
In a press release, Baxter’s chairman Jose E. Almeida stated:
The Baxter-Hillrom combination unlocks the next phase of our transformation, presenting a new wave of potential to drive greater impact for patients, clinicians, employees, shareholders and other communities we serve worldwide. Integrating our complementary capabilities introduces additional opportunities for growth across our broad geographic footprint and also creates remarkable new possibilities for connectivity with leading-edge digital health innovation focused on enhancing care, lowering costs and increasing workflow efficiency.
According to the press release, Baxter expects the combination to result in ~$250 million of annual pre-tax cost synergies within 3 years.